Chaos in the organization of any human or animal movement has its own parameters in the form of quasi-attractors, and these parameters (quasi-attractors) have a diagnostically significant value. Motor activity of any biological entity in biomechanics consists of a real superposition of voluntary acts (i.e., having a goal and the mechanisms of its implementation) and an obligatory element of chaos when the arbitrary motor activity cannot really be implemented arbitrarily. This paper presents examples of the practical implementation of the parameters of chaos in clinical medicine and their diagnostic value.
{"title":"Evaluation of Movements in Tapping and Tremor from the Viewpoint of the Theory of Chaos and Self-Organization","authors":"A. Khadartsev, V. Eskov, Weidong Pan","doi":"10.1159/000446281","DOIUrl":"https://doi.org/10.1159/000446281","url":null,"abstract":"Chaos in the organization of any human or animal movement has its own parameters in the form of quasi-attractors, and these parameters (quasi-attractors) have a diagnostically significant value. Motor activity of any biological entity in biomechanics consists of a real superposition of voluntary acts (i.e., having a goal and the mechanisms of its implementation) and an obligatory element of chaos when the arbitrary motor activity cannot really be implemented arbitrarily. This paper presents examples of the practical implementation of the parameters of chaos in clinical medicine and their diagnostic value.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"89 - 95"},"PeriodicalIF":0.0,"publicationDate":"2016-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000446281","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65066105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Gutierrez, Helga Codina, Cesar Benjamin Matamoros Pinel, Edin Hidalgo, Arturo Arellano, M. V. Rey, S. Pérez-Lloret
Background/Aims: To explore the effects of ibandronate plus a supplementation of vitamin D and calcium on bone mineral density (BMD) and health-related quality of life (HRQoL) in a sample of postmenopausal women from Central America. Secondarily, factors related to the magnitude of improvements in BMD after treatment were investigated. Methods: Postmenopausal women with idiopathic osteoporosis or at risk of developing it, who were going to start treatment with ibandronate 150 mg once a month plus daily supplementation with vitamin D 400-800 IU and calcium 500-1,000 mg, were followed up for 6 months. BMD, HRQoL (mini-Osteoporosis Quality of Life Questionnaire), and treatment adherence (Morisky scale) were studied before and after treatment. Results: Four hundred and twenty-five women were assessed at baseline, and 308 (72%) were reassessed at month 6. Lumbar spine, proximal femur, and hip BMD increased by 3.35 ± 0.75, 1.88 ± 0.50, and 2.75 ± 0.32%, respectively (p < 0.001 for all). HRQoL total score and emotional functioning, symptoms, physical function, and leisure subscores improved by 26-49% (p < 0.01 in all cases). Lower body mass index, younger age at menopause, use of corticoids, and higher adherence were significantly and independently associated with a greater improvement in lumbar spine BMD (logistic regression). Conclusion: Improvements in BMD and HRQoL after ibandronate, vitamin D, and calcium were observed in patients from Central America, which should be confirmed by double-blind, randomized, controlled trials. Lack of adherence to ibandronate was related to worse outcomes, thus highlighting the need for work on this issue with patients on treatment.
{"title":"Clinical Effects of a 6-Month Treatment Course of Ibandronate, Vitamin D, and Calcium in Postmenopausal Women from Central America: Results of a Multinational, Prospective Pilot Study","authors":"C. Gutierrez, Helga Codina, Cesar Benjamin Matamoros Pinel, Edin Hidalgo, Arturo Arellano, M. V. Rey, S. Pérez-Lloret","doi":"10.1159/000448478","DOIUrl":"https://doi.org/10.1159/000448478","url":null,"abstract":"Background/Aims: To explore the effects of ibandronate plus a supplementation of vitamin D and calcium on bone mineral density (BMD) and health-related quality of life (HRQoL) in a sample of postmenopausal women from Central America. Secondarily, factors related to the magnitude of improvements in BMD after treatment were investigated. Methods: Postmenopausal women with idiopathic osteoporosis or at risk of developing it, who were going to start treatment with ibandronate 150 mg once a month plus daily supplementation with vitamin D 400-800 IU and calcium 500-1,000 mg, were followed up for 6 months. BMD, HRQoL (mini-Osteoporosis Quality of Life Questionnaire), and treatment adherence (Morisky scale) were studied before and after treatment. Results: Four hundred and twenty-five women were assessed at baseline, and 308 (72%) were reassessed at month 6. Lumbar spine, proximal femur, and hip BMD increased by 3.35 ± 0.75, 1.88 ± 0.50, and 2.75 ± 0.32%, respectively (p < 0.001 for all). HRQoL total score and emotional functioning, symptoms, physical function, and leisure subscores improved by 26-49% (p < 0.01 in all cases). Lower body mass index, younger age at menopause, use of corticoids, and higher adherence were significantly and independently associated with a greater improvement in lumbar spine BMD (logistic regression). Conclusion: Improvements in BMD and HRQoL after ibandronate, vitamin D, and calcium were observed in patients from Central America, which should be confirmed by double-blind, randomized, controlled trials. Lack of adherence to ibandronate was related to worse outcomes, thus highlighting the need for work on this issue with patients on treatment.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"82 - 88"},"PeriodicalIF":0.0,"publicationDate":"2016-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000448478","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65099413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Laser medicine in general has experienced enormous progress over the last years. The latest innovation is a so-called laser watch, a system only slightly larger than a wrist watch. Methods: The laser watch is applied to the wrist, where simultaneous and continuous acupuncture point or blood irradiation using laser light can be performed. Results: This results in new and promising therapeutic approaches for different diseases. This article introduces and briefly discusses the first pilot measurements with regard to the laser watch. Conclusion: The laser watch is practicable; however, further research is absolutely necessary before the laser watch is widely used.
{"title":"A Laser Watch for Simultaneous Laser Blood Irradiation and Laser Acupuncture at the Wrist","authors":"G. Litscher, D. Litscher","doi":"10.1159/000448099","DOIUrl":"https://doi.org/10.1159/000448099","url":null,"abstract":"Background: Laser medicine in general has experienced enormous progress over the last years. The latest innovation is a so-called laser watch, a system only slightly larger than a wrist watch. Methods: The laser watch is applied to the wrist, where simultaneous and continuous acupuncture point or blood irradiation using laser light can be performed. Results: This results in new and promising therapeutic approaches for different diseases. This article introduces and briefly discusses the first pilot measurements with regard to the laser watch. Conclusion: The laser watch is practicable; however, further research is absolutely necessary before the laser watch is widely used.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"75 - 81"},"PeriodicalIF":0.0,"publicationDate":"2016-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000448099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65092506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Researchers and clinicians in integrative medicine (IM) are well aware that the research and reporting methods they use should be as scientifically rigorous as those used in conventional medicine. To establish the scientific evidence needed to promote the further adoption of traditional medicine (TM) and complementary and alternative medicine (CAM) into healthcare systems worldwide, it is important that doctors of IM publish their findings in English. The English-language, cross-disciplinary journal Integrative Medicine International aims to publish such work, by focusing on reporting ‘new methods in [TM/CAM] research and therapy to complement and extend the methods of Western medicine'. The journal acts as a portal for the latest innovations, developments, trends, opinions, and achievements in TM. The purpose of this editorial is to encourage and support authors across a wide range of disciplines to report their research and clinical findings in IM. The article starts by explaining the process of preparing a suitable manuscript for the journal and then describes the general process of manuscript preparation, peer review, and publication that is common to many international journals. Some advices are also given to authors who are nonnative speakers to help them submit manuscripts of sufficient quality of English for review and in accordance with ethical publishing standards.
综合医学(IM)的研究人员和临床医生很清楚，他们使用的研究和报告方法应该像传统医学中使用的方法一样在科学上严格。为了建立促进传统医学(TM)和补充和替代医学(CAM)进一步进入全球卫生保健系统所需的科学证据，IM医生用英语发表他们的发现是很重要的。英文、跨学科期刊《国际中西医结合》(Integrative Medicine International)的目标是发表这样的研究成果，重点报道“[TM/CAM]研究和治疗中的新方法，以补充和扩展西方医学的方法”。该杂志是TM领域最新创新、发展、趋势、观点和成就的门户。这篇社论的目的是鼓励和支持各个学科的作者在IM杂志上报告他们的研究和临床发现。这篇文章首先解释了为期刊准备一份合适的手稿的过程，然后描述了许多国际期刊共同的手稿准备、同行评审和出版的一般过程。对于非英语为母语的作者，也给出了一些建议，帮助他们提交足够质量的英文稿件供评审，并符合道德出版标准。
{"title":"Advancing the Adoption of Integrative Medicine: A Quick Guide to Publishing Research in Integrative Medicine International","authors":"Weidong Pan, C. Jones","doi":"10.1159/000448037","DOIUrl":"https://doi.org/10.1159/000448037","url":null,"abstract":"Researchers and clinicians in integrative medicine (IM) are well aware that the research and reporting methods they use should be as scientifically rigorous as those used in conventional medicine. To establish the scientific evidence needed to promote the further adoption of traditional medicine (TM) and complementary and alternative medicine (CAM) into healthcare systems worldwide, it is important that doctors of IM publish their findings in English. The English-language, cross-disciplinary journal Integrative Medicine International aims to publish such work, by focusing on reporting ‘new methods in [TM/CAM] research and therapy to complement and extend the methods of Western medicine'. The journal acts as a portal for the latest innovations, developments, trends, opinions, and achievements in TM. The purpose of this editorial is to encourage and support authors across a wide range of disciplines to report their research and clinical findings in IM. The article starts by explaining the process of preparing a suitable manuscript for the journal and then describes the general process of manuscript preparation, peer review, and publication that is common to many international journals. Some advices are also given to authors who are nonnative speakers to help them submit manuscripts of sufficient quality of English for review and in accordance with ethical publishing standards.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"68 - 74"},"PeriodicalIF":0.0,"publicationDate":"2016-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000448037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65091705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Oriental medicine is based on the 5-phase theory, in which the balance among the 5 viscera - the liver, the heart, the spleen, the lung and the kidney - is important. It is confusing that the viscera in Oriental and Occidental medicine have the same name. Out of the 5 viscera in Oriental medicine, it is the spleen that differs most from that in Occidental medicine. It mainly corresponds to the digestive organs and pancreas and has no relation to the spleen in Occidental medicine, a kind of lymph tissue. On the other hand, the concept of each of the other Oriental viscera includes the corresponding viscus in Occidental medicine. Key Messages: The 11 aspects of the kidney in Oriental medicine correspond to three kinds of endocrine and metabolic systems, all of which are associated with aging.
{"title":"Kidneys in Oriental and Occidental Medicine","authors":"T. Kondo","doi":"10.1159/000447491","DOIUrl":"https://doi.org/10.1159/000447491","url":null,"abstract":"Background: Oriental medicine is based on the 5-phase theory, in which the balance among the 5 viscera - the liver, the heart, the spleen, the lung and the kidney - is important. It is confusing that the viscera in Oriental and Occidental medicine have the same name. Out of the 5 viscera in Oriental medicine, it is the spleen that differs most from that in Occidental medicine. It mainly corresponds to the digestive organs and pancreas and has no relation to the spleen in Occidental medicine, a kind of lymph tissue. On the other hand, the concept of each of the other Oriental viscera includes the corresponding viscus in Occidental medicine. Key Messages: The 11 aspects of the kidney in Oriental medicine correspond to three kinds of endocrine and metabolic systems, all of which are associated with aging.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"52 1","pages":"64 - 67"},"PeriodicalIF":0.0,"publicationDate":"2016-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000447491","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65078311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T helper 17 (Th17) cells are one of the CD4+ T-cell subsets which induce a variety of diseases by secreting IL-17 and other inflammatory factors. After Helicobacter pylori (Hp) infection, cytotoxin-associated gene A and urease subunit B regulate the number of Th17 cells via induction of cell differentiation by infected macrophages, activation of MyD88 and other pathways, and by driving chemokines, which upregulates the number of both Th17 cells and regulatory T cells (Tregs) and switches towards a Treg-type immune response. Meanwhile, Th17 cells also play important roles in the response to Hp infection, participating in the clearance of Hp by recruiting neutrophils and expanding inflammatory response, causing mucosal damage and even inducing cancer. Thereby, Th17 cells participate in the occurrence and development of Hp-related diseases, such as gastritis, peptic ulcer disease and gastric cancer.
{"title":"Immune Responses Mediated by Th17 Cells in Helicobacter pylori Infection","authors":"Chang Liu, Zhengli Zhang, Meiping Zhu","doi":"10.1159/000446317","DOIUrl":"https://doi.org/10.1159/000446317","url":null,"abstract":"T helper 17 (Th17) cells are one of the CD4+ T-cell subsets which induce a variety of diseases by secreting IL-17 and other inflammatory factors. After Helicobacter pylori (Hp) infection, cytotoxin-associated gene A and urease subunit B regulate the number of Th17 cells via induction of cell differentiation by infected macrophages, activation of MyD88 and other pathways, and by driving chemokines, which upregulates the number of both Th17 cells and regulatory T cells (Tregs) and switches towards a Treg-type immune response. Meanwhile, Th17 cells also play important roles in the response to Hp infection, participating in the clearance of Hp by recruiting neutrophils and expanding inflammatory response, causing mucosal damage and even inducing cancer. Thereby, Th17 cells participate in the occurrence and development of Hp-related diseases, such as gastritis, peptic ulcer disease and gastric cancer.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"57 - 63"},"PeriodicalIF":0.0,"publicationDate":"2016-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000446317","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65066636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xin Sun, Tao Yang, Chunwu Zhu, Hai-nan Wang, Cheng-hai Liu
Herbal medicine (HM) has been widely used to prevent and treat diseases for thousands of years. However, recent increasing evidence shows that HM-induced liver injury (HILI) is not something to be ignored. In fact, herbal toxicity has always been recognized and emphasized in the long history of Traditional Chinese Medicine. In this article, we analyzed the situation of HILI in China and its risk factors in detail. In addition, the legal regime of the HM industry in contemporary China is introduced. Recently, the mechanisms of HILI have been widely studied, and epidemiological investigations into HILI have been conducted. In the future, a comprehensive platform for research and communication could help facilitate the development of strategies to predict and prevent HILI.
{"title":"Herbal Medicine-Induced Liver Injury in China","authors":"Xin Sun, Tao Yang, Chunwu Zhu, Hai-nan Wang, Cheng-hai Liu","doi":"10.1159/000444485","DOIUrl":"https://doi.org/10.1159/000444485","url":null,"abstract":"Herbal medicine (HM) has been widely used to prevent and treat diseases for thousands of years. However, recent increasing evidence shows that HM-induced liver injury (HILI) is not something to be ignored. In fact, herbal toxicity has always been recognized and emphasized in the long history of Traditional Chinese Medicine. In this article, we analyzed the situation of HILI in China and its risk factors in detail. In addition, the legal regime of the HM industry in contemporary China is introduced. Recently, the mechanisms of HILI have been widely studied, and epidemiological investigations into HILI have been conducted. In the future, a comprehensive platform for research and communication could help facilitate the development of strategies to predict and prevent HILI.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"53 - 56"},"PeriodicalIF":0.0,"publicationDate":"2016-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000444485","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65045164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stroke is the leading cause of death and disability worldwide, and ischemic stroke accounts for more than 85% of the stroke incidence. Tissue plasminogen activator (t-PA) is the only FDA-approved drug for ischemic stroke treatment with a narrow treatment time window of 4.5 h. Hemorrhagic transformation (HT) is a severe complication of delayed t-PA treatment in ischemic stroke. Thus, it is critically important to develop combination therapies to reduce HT and extend the therapeutic time window of t-PA. Current progress suggests that peroxynitrite (ONOO-)/high-mobility group box 1 protein (HMGB1)/matrix metalloproteinase-9 (MMP-9) signaling cascades could be important for attenuating HT during thrombolytic treatment for acute ischemic stroke. Recently, important progress has been made in seeking for natural compounds from Chinese medicine for reducing ischemic stroke injury, with some of them targeting ONOO-/HMGB1/MMP-9 signaling cascades. Herein, we analyze the roles and interactions of these three targets in mediating HT; subsequently, we summarize the potential compounds from Chinese herbal medicine for attenuating HT and analyze the related targets. Finally, we raise the potential issues to be addressed in further development of these compounds as combination therapy.
{"title":"Targeting ONOO-/HMGB1/MMP-9 Signaling Cascades: Potential for Drug Development from Chinese Medicine to Attenuate Ischemic Brain Injury and Hemorrhagic Transformation Induced by Thrombolytic Treatment","authors":"Hansen Chen, Binghe Guan, Jiangang Shen","doi":"10.1159/000442468","DOIUrl":"https://doi.org/10.1159/000442468","url":null,"abstract":"Stroke is the leading cause of death and disability worldwide, and ischemic stroke accounts for more than 85% of the stroke incidence. Tissue plasminogen activator (t-PA) is the only FDA-approved drug for ischemic stroke treatment with a narrow treatment time window of 4.5 h. Hemorrhagic transformation (HT) is a severe complication of delayed t-PA treatment in ischemic stroke. Thus, it is critically important to develop combination therapies to reduce HT and extend the therapeutic time window of t-PA. Current progress suggests that peroxynitrite (ONOO-)/high-mobility group box 1 protein (HMGB1)/matrix metalloproteinase-9 (MMP-9) signaling cascades could be important for attenuating HT during thrombolytic treatment for acute ischemic stroke. Recently, important progress has been made in seeking for natural compounds from Chinese medicine for reducing ischemic stroke injury, with some of them targeting ONOO-/HMGB1/MMP-9 signaling cascades. Herein, we analyze the roles and interactions of these three targets in mediating HT; subsequently, we summarize the potential compounds from Chinese herbal medicine for attenuating HT and analyze the related targets. Finally, we raise the potential issues to be addressed in further development of these compounds as combination therapy.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"32 - 52"},"PeriodicalIF":0.0,"publicationDate":"2016-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000442468","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64978940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Belyaeva, A. Khadartsev, I. Fedorischev, A. S. Sazonov
This study presents postmenopausal osteoporosis as a feature of metabolic systemic diseases of the skeleton, with abnormalities of the bone microarchitecture and reduction in bone mineral density, leading to an increased risk of fractures with a low level of trauma. The neurological manifestations of such fractures are uncharacteristic, representing a differential diagnostic indication. There is a change of posture in the form of hyperkyphosis of the thoracic spine and loss of height due to the increase in the number of modified vertebrae. The age of these patients is between 66 and 68 years, which limits the use of traditional analgesic preparations. The ionized gel ‘Giasulf' was applied in 29 cases according to the developed technology. The description of the composition of the gel that provides maximum analgesic effect, reinforced by the influence of laser radiation on the cell membranes, is presented. A significant antinociceptive effect was obtained.
{"title":"Application of Laser Phoresis in Complicated Postmenopausal Osteoporosis","authors":"E. Belyaeva, A. Khadartsev, I. Fedorischev, A. S. Sazonov","doi":"10.1159/000442669","DOIUrl":"https://doi.org/10.1159/000442669","url":null,"abstract":"This study presents postmenopausal osteoporosis as a feature of metabolic systemic diseases of the skeleton, with abnormalities of the bone microarchitecture and reduction in bone mineral density, leading to an increased risk of fractures with a low level of trauma. The neurological manifestations of such fractures are uncharacteristic, representing a differential diagnostic indication. There is a change of posture in the form of hyperkyphosis of the thoracic spine and loss of height due to the increase in the number of modified vertebrae. The age of these patients is between 66 and 68 years, which limits the use of traditional analgesic preparations. The ionized gel ‘Giasulf' was applied in 29 cases according to the developed technology. The description of the composition of the gel that provides maximum analgesic effect, reinforced by the influence of laser radiation on the cell membranes, is presented. A significant antinociceptive effect was obtained.","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"17 - 23"},"PeriodicalIF":0.0,"publicationDate":"2016-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000442669","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64983655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Helga Codina, C. Gutierrez, C. Pinel, Edin Hidalgo, Arturo Arellano, M. V. Rey, S. Pérez-Lloret, G. Meshram, P. Bhajoni, M. Lahkar, Jiangang Shen, Hansen Chen, Binghe Guan, Weidong Pan, C. Jones, A. Khadartsev, E. Belyaeva, I. Fedorischev, A. S. Sazonov, T. Kondo, Chang Liu, Zhengli Zhang, Meiping Zhu, D. Litscher, G. Litscher, Xin Sun, Hai-nan Wang, Tao Yang, Chunwu Zhu, Cheng-hai Liu, V. Eskov, Druckerei Stückle
{"title":"SCN's 1st Annual Congress of Neuroendocrinology, Neuroimmunology and Chinese Integrative Medicine, and Gongji Stroke Forum. Shanghai General Hospital. Shanghai, China, November 19-20, 2015: Abstracts","authors":"Helga Codina, C. Gutierrez, C. Pinel, Edin Hidalgo, Arturo Arellano, M. V. Rey, S. Pérez-Lloret, G. Meshram, P. Bhajoni, M. Lahkar, Jiangang Shen, Hansen Chen, Binghe Guan, Weidong Pan, C. Jones, A. Khadartsev, E. Belyaeva, I. Fedorischev, A. S. Sazonov, T. Kondo, Chang Liu, Zhengli Zhang, Meiping Zhu, D. Litscher, G. Litscher, Xin Sun, Hai-nan Wang, Tao Yang, Chunwu Zhu, Cheng-hai Liu, V. Eskov, Druckerei Stückle","doi":"10.1159/000443318","DOIUrl":"https://doi.org/10.1159/000443318","url":null,"abstract":"","PeriodicalId":91502,"journal":{"name":"Integrative medicine international","volume":"3 1","pages":"24 - 31"},"PeriodicalIF":0.0,"publicationDate":"2016-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000443318","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65010363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：